These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 8040673)

  • 1. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
    J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group].
    Röttinger EM
    Strahlenther Onkol; 1995 May; 171(5):303-4. PubMed ID: 7770788
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
    Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
    J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.
    Jakacki RI; Zeltzer PM; Boyett JM; Albright AL; Allen JC; Geyer JR; Rorke LB; Stanley P; Stevens KR; Wisoff J
    J Clin Oncol; 1995 Jun; 13(6):1377-83. PubMed ID: 7751882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
    Grill J; Le Deley MC; Gambarelli D; Raquin MA; Couanet D; Pierre-Kahn A; Habrand JL; Doz F; Frappaz D; Gentet JC; Edan C; Chastagner P; Kalifa C;
    J Clin Oncol; 2001 Mar; 19(5):1288-96. PubMed ID: 11230470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
    Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
    J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for brain tumors in infants and young children.
    Iwama J; Ogiwara H; Kiyotani C; Terashima K; Matsuoka K; Iwafuchi H; Morota N
    J Neurosurg Pediatr; 2015 May; 15(5):488-92. PubMed ID: 25723725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
    Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
    J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    Al-Hader AA; Jain A; Al-Nasrallah N; Einhorn LH
    Am J Clin Oncol; 2015 Aug; 38(4):364-6. PubMed ID: 23799289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.
    Duffner PK; Horowitz ME; Krischer JP; Friedman HS; Burger PC; Cohen ME; Sanford RA; Mulhern RK; James HE; Freeman CR
    N Engl J Med; 1993 Jun; 328(24):1725-31. PubMed ID: 8388548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
    White L; Kellie S; Gray E; Toogood I; Waters K; Lockwood L; Macfarlane S; Johnston H
    J Pediatr Hematol Oncol; 1998; 20(2):125-30. PubMed ID: 9544162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.
    Grundy RG; Wilne SA; Weston CL; Robinson K; Lashford LS; Ironside J; Cox T; Chong WK; Campbell RH; Bailey CC; Gattamaneni R; Picton S; Thorpe N; Mallucci C; English MW; Punt JA; Walker DA; Ellison DW; Machin D;
    Lancet Oncol; 2007 Aug; 8(8):696-705. PubMed ID: 17644039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.
    Ater JL; van Eys J; Woo SY; Moore B; Copeland DR; Bruner J
    J Neurooncol; 1997 May; 32(3):243-52. PubMed ID: 9049886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group.
    Geyer JR; Finlay JL; Boyett JM; Wisoff J; Yates A; Mao L; Packer RJ
    Cancer; 1995 Feb; 75(4):1045-50. PubMed ID: 7842407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group.
    Jakacki RI; Burger PC; Kocak M; Boyett JM; Goldwein J; Mehta M; Packer RJ; Tarbell NJ; Pollack IF
    Pediatr Blood Cancer; 2015 May; 62(5):776-83. PubMed ID: 25704363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ependymal tumors in childhood.
    Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
    Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.